DaShenLin Pharmaceutical Group Co Ltd Intrinsic Valuation and Fundamental Analysis - DaShenLin Pharmaceutical Group Co Ltd

D	DaShenLin Pharmaceutical Group Co Ltd SSE:603233	CN
	Q2 Metals Corp F:458	CA

Intrinsic Value

The intrinsic value for DaShenLin Pharmaceutical Group Co Ltd (603233) under the Base Case is 30.12 CNY. Compared with the current market price of 19.25 CNY, the stock appears Undervalued by 36% .

DCF Value

¥37.56

Multiples-Based Value

¥22.69

DCF Value

¥37.56

Multiples-Based Value

¥22.69

Both DCF and multiples point to undervaluation.

Why combine DCF with multiples? What is Intrinsic Value?

Intrinsic Value

Undervaluation 36%

Intrinsic Value

Price ¥19.25

D

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value ¥24.1

Get notified when the price drops into your buy zone

Intrinsic Value ¥30.12

Margin of Safety 20% ¥24.1

Current Price ¥19.25

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for DaShenLin Pharmaceutical Group Co Ltd.

Explain Valuation